Novo Nordisk – Insulin Glargine (Lantus) Study

Enroll Now

Type of Study:

Type 2 diabetes patients who are between 18 to 75 years without injection medications

Title of Study:

This study will assess a once a week insulin to a daily insulin in patients with Type 2 diabetes

Short Title:

NN 4465

Study Length: 5 months

Target Age/Sex: 18-75 years, Male and Female

Benefits:

Participants will receive at no cost: study product, study materials and study-specific procedures

Link: ClinicalTrials.gov